NM_182919.4:c.95C>T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_182919.4(TICAM1):​c.95C>T​(p.Thr32Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00146 in 1,612,904 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0014 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 48 hom. )

Consequence

TICAM1
NM_182919.4 missense

Scores

4
14

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0660

Publications

5 publications found
Variant links:
Genes affected
TICAM1 (HGNC:18348): (TIR domain containing adaptor molecule 1) This gene encodes an adaptor protein containing a Toll/interleukin-1 receptor (TIR) homology domain, which is an intracellular signaling domain that mediates protein-protein interactions between the Toll-like receptors (TLRs) and signal-transduction components. This protein is involved in native immunity against invading pathogens. It specifically interacts with toll-like receptor 3, but not with other TLRs, and this association mediates dsRNA induction of interferon-beta through activation of nuclear factor kappa-B, during an antiviral immune response. Mutations in this gene are associated with encephalopathy, acute, infection-induced. [provided by RefSeq, Jul 2020]
TICAM1 Gene-Disease associations (from GenCC):
  • herpes simplex encephalitis, susceptibility to, 4
    Inheritance: AR, SD, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0027892292).
BP6
Variant 19-4818283-G-A is Benign according to our data. Variant chr19-4818283-G-A is described in ClinVar as Benign. ClinVar VariationId is 540521.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00141 (215/152320) while in subpopulation EAS AF = 0.0357 (185/5182). AF 95% confidence interval is 0.0315. There are 2 homozygotes in GnomAd4. There are 129 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,SD,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TICAM1NM_182919.4 linkc.95C>T p.Thr32Ile missense_variant Exon 2 of 2 ENST00000248244.6 NP_891549.1 Q8IUC6
TICAM1NM_001385678.1 linkc.53C>T p.Thr18Ile missense_variant Exon 3 of 3 NP_001372607.1
TICAM1NM_001385679.1 linkc.-41C>T 5_prime_UTR_variant Exon 2 of 2 NP_001372608.1
TICAM1NM_001385680.1 linkc.-72+101C>T intron_variant Intron 2 of 2 NP_001372609.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TICAM1ENST00000248244.6 linkc.95C>T p.Thr32Ile missense_variant Exon 2 of 2 1 NM_182919.4 ENSP00000248244.4 Q8IUC6

Frequencies

GnomAD3 genomes
AF:
0.00142
AC:
216
AN:
152202
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.0358
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00313
AC:
780
AN:
249220
AF XY:
0.00293
show subpopulations
Gnomad AFR exome
AF:
0.0000621
Gnomad AMR exome
AF:
0.0000868
Gnomad ASJ exome
AF:
0.000697
Gnomad EAS exome
AF:
0.0372
Gnomad FIN exome
AF:
0.0000972
Gnomad NFE exome
AF:
0.000337
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00147
AC:
2144
AN:
1460584
Hom.:
48
Cov.:
80
AF XY:
0.00147
AC XY:
1066
AN XY:
726620
show subpopulations
African (AFR)
AF:
0.000119
AC:
4
AN:
33480
American (AMR)
AF:
0.000112
AC:
5
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.000421
AC:
11
AN:
26132
East Asian (EAS)
AF:
0.0423
AC:
1679
AN:
39700
South Asian (SAS)
AF:
0.00153
AC:
132
AN:
86258
European-Finnish (FIN)
AF:
0.000115
AC:
6
AN:
52176
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5766
European-Non Finnish (NFE)
AF:
0.000160
AC:
178
AN:
1111978
Other (OTH)
AF:
0.00209
AC:
126
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
137
274
411
548
685
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00141
AC:
215
AN:
152320
Hom.:
2
Cov.:
32
AF XY:
0.00173
AC XY:
129
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41578
American (AMR)
AF:
0.000131
AC:
2
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.0357
AC:
185
AN:
5182
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
68020
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00154
Hom.:
5
Bravo
AF:
0.00181
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00299
AC:
363
Asia WGS
AF:
0.0150
AC:
52
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000356

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Herpes simplex encephalitis, susceptibility to, 4 Benign:1
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.26
T
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.49
T
MetaRNN
Benign
0.0028
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
0.066
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-2.1
N
REVEL
Benign
0.041
Sift
Uncertain
0.011
D
Sift4G
Uncertain
0.043
D
Polyphen
0.92
P
Vest4
0.27
MVP
0.11
MPC
0.47
ClinPred
0.026
T
GERP RS
-0.46
Varity_R
0.11
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79591246; hg19: chr19-4818295; COSMIC: COSV50230355; COSMIC: COSV50230355; API